©2026 Incunabulum LLC. All rights reserved. mg Magazine is a registered trademark of Incunabulum LLC. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with prior written permission.
Tag: PathogenDX
PathogenDx Launches the Cannabis Industry’s First AOAC Certified Rapid Semi-Quantification Test for Total Yeast...
SCOTTSDALE, Az. -- PathogenDx (PathogenDx or Company), a leader in next-generation microarray technology for better health and safety, announced the launch of its new and improved...
PathogenDx Enables Labs to Meet Cannabis Testing Regulations in Every State With Launch of...
SCOTTSDALE, Ariz. –
PathogenDx, a leader in next-generation microarray technology for better health and safety, announced the launch of QuantX Bacterial, a new rapid...
PathogenDx Announces $7.5 Million in Series B Funding
TUCSON, Ariz. – PathogenDx, Inc., an innovator in DNA-based pathogen testing technology for the cannabis, hemp, agriculture and food safety industries, today announced $7.5...
How Successful Cannabis Executives Handle Traveling for Work
Legal cannabis may be growing at unprecedented rates but the industry is still relatively new, requiring old fashioned face to face networking. Executives know...
Altitude Investment Management Closes Cannabis Fund I at $30M
NEW YORK––(November 27, 2018) Altitude Investment Management, LLC (“Altitude”) announced today that it will close Fund I on November 30, 2018 with $30 million...